Eli Lilly : LLY

All Eli Lilly Articles

655 Articles

Jeremy Phillips | Jun 3, 2026 at 8:38 AM EDT

5 Stocks Set to Cash in on The Next 90-Million Customer Industry. (It’s Not AI)

Wells Fargo’s chief agriculture economist Dr. Michael Swanson told Bloomberg Businessweek on May 29 that GLP-1 weight-loss drugs (Ozempic, Wegovy,…

Thomas Richmond | Jun 1, 2026 at 11:35 AM EDT

Eli Lilly Growing at 55% as a Trillion-Dollar Company: ‘These Are NVIDIA-Like Growth Numbers’

Macro strategist Jordi Visser delivered a striking observation on a recent episode of The Pomp Podcast with Anthony Pompliano. Among…

Omor Ibne Ehsan | May 27, 2026 at 3:45 PM EDT

Buy, Sell, or Hold Vanguard’s Mega Cap Growth ETF Right Now | MGK

There’s a tech ETF that has been almost neck-and-neck with the S&P 500 in the past year and has built…

Trey Thoelcke | May 26, 2026 at 8:50 AM EDT

If Viking Therapeutics Is Acquired, Here’s Who Wins

Polymarket traders are watching one biotech more closely than any other for an acquisition. Viking Therapeutics (NASDAQ: VKTX | VKTX…

Michael Williams | May 25, 2026 at 9:30 AM EDT

VIG Investors: Watch the 10-Year Treasury Yield This Week—4.75% Is the Danger Line

The Vanguard Dividend Appreciation Index Fund ETF Shares (NYSEARCA:VIG) is having a quieter year than its big-cap dividend-growth reputation suggests,…

Trey Thoelcke | May 21, 2026 at 9:05 AM EDT

Will ASML, Lilly, or TransDigm Be the Next Big Stock Split?

Wall Street has rediscovered the stock-split playbook. KLA (NASDAQ: KLAC | KLAC Price Prediction) announced a 10-for-1 forward stock split in…

Vandita Jadeja | May 21, 2026 at 8:25 AM EDT

Can Eli Lilly Stock Reach $1800 by 2030? Here Is the Bull Case

Eli Lilly (NYSE:LLY | LLY Price Prediction) is growing like a software company. Q1 2026 revenue hit $19.80B, up 55.5%…

Don Lair | May 20, 2026 at 1:22 AM EDT

“4,000% or 5,000% Over Five or Six Years”: Why Patient Investors in NVDA, AMD, and LLY Are Winning

On a recent episode of Earn Your Leisure titled “The #1 Investing Mistake Keeping You Broke,” co-host E delivered a…

Omor Ibne Ehsan | May 19, 2026 at 4:19 PM EDT

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

The iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is the rare fund that has spent the past year being publicly threatened by…

Omor Ibne Ehsan | May 19, 2026 at 11:12 AM EDT

If You Hold This Healthcare ETF, You’re Losing Big

The Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) is down about 5% year to date while the S&P 500 is…

Alex Sirois | May 18, 2026 at 1:55 PM EDT

Three Biotechs That Are Top Takeover Targets

Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to talk about, and the reasons are obvious:…

Thomas Richmond | May 15, 2026 at 10:35 AM EDT

Prediction. The S&P 500 Is So Far Above Its Moving Averages That a 10% Correction This Summer Is Not Out of the Question

Lance Roberts of RIA Advisors warned on the Thoughtful Money podcast that the S&P 500 has stretched so far above…

Vandita Jadeja | May 14, 2026 at 1:34 PM EDT

Is Eli Lilly Going To $1,100?

Eli Lilly (NYSE:LLY | LLY Price Prediction) just delivered one of the most impressive quarters in big pharma history, and…

Vandita Jadeja | May 12, 2026 at 11:25 AM EDT

Eli Lilly Price Prediction: This Is Where The Stock Will End This Year

Few stocks have polarized investors in 2026 like Eli Lilly (NYSE:LLY | LLY Price Prediction). After a stunning Q1 earnings…

Trey Thoelcke | May 12, 2026 at 7:40 AM EDT

Lilly Bounces Into ‘Sell in May’ Territory as Pricing Pressures Loom

The market adage “Sell in May and Go Away” rarely fits a single name cleanly. Eli Lilly (NYSE: LLY |…

1 2 3 4 … 44

Eli Lilly : LLY

All Eli Lilly Articles

5 Stocks Set to Cash in on The Next 90-Million Customer Industry. (It’s Not AI)

Eli Lilly Growing at 55% as a Trillion-Dollar Company: ‘These Are NVIDIA-Like Growth Numbers’

Buy, Sell, or Hold Vanguard’s Mega Cap Growth ETF Right Now | MGK

If Viking Therapeutics Is Acquired, Here’s Who Wins

VIG Investors: Watch the 10-Year Treasury Yield This Week—4.75% Is the Danger Line

Will ASML, Lilly, or TransDigm Be the Next Big Stock Split?

Can Eli Lilly Stock Reach $1800 by 2030? Here Is the Bull Case

“4,000% or 5,000% Over Five or Six Years”: Why Patient Investors in NVDA, AMD, and LLY Are Winning

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

If You Hold This Healthcare ETF, You’re Losing Big

Three Biotechs That Are Top Takeover Targets

Prediction. The S&P 500 Is So Far Above Its Moving Averages That a 10% Correction This Summer Is Not Out of the Question

Is Eli Lilly Going To $1,100?

Eli Lilly Price Prediction: This Is Where The Stock Will End This Year

Lilly Bounces Into ‘Sell in May’ Territory as Pricing Pressures Loom

The “G-Wagon Loophole”: How Business Owners Write Off a $100,000 SUV the Year They Buy It

‘$13,426 of Stupid’: Dave Ramsey’s Blunt Advice to a Caller Who Maxed Out Credit Cards Flipping Pokemon Cards

The Next 30% Crash Will Happen. These 3 ETFs Mean You Won’t Panic-Sell at the Bottom

'$13,426 of Stupid': Dave Ramsey's Blunt Advice to a Caller Who Maxed Out Credit Cards Flipping Pokemon Cards

How Corporate Executives Stash $100,000+ Into a 401(k) Using the 415(c) Rule Most People Miss

The “G-Wagon Loophole”: How Business Owners Write Off a $100,000 SUV the Year They Buy It

‘$13,426 of Stupid’: Dave Ramsey’s Blunt Advice to a Caller Who Maxed Out Credit Cards Flipping Pokemon Cards

Eli Lilly : LLY

All Eli Lilly Articles

5 Stocks Set to Cash in on The Next 90-Million Customer Industry. (It’s Not AI)

Eli Lilly Growing at 55% as a Trillion-Dollar Company: ‘These Are NVIDIA-Like Growth Numbers’

Buy, Sell, or Hold Vanguard’s Mega Cap Growth ETF Right Now | MGK

If Viking Therapeutics Is Acquired, Here’s Who Wins

VIG Investors: Watch the 10-Year Treasury Yield This Week—4.75% Is the Danger Line

Will ASML, Lilly, or TransDigm Be the Next Big Stock Split?

Can Eli Lilly Stock Reach $1800 by 2030? Here Is the Bull Case

“4,000% or 5,000% Over Five or Six Years”: Why Patient Investors in NVDA, AMD, and LLY Are Winning

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

If You Hold This Healthcare ETF, You’re Losing Big

Three Biotechs That Are Top Takeover Targets

Prediction. The S&P 500 Is So Far Above Its Moving Averages That a 10% Correction This Summer Is Not Out of the Question

Is Eli Lilly Going To $1,100?

Eli Lilly Price Prediction: This Is Where The Stock Will End This Year

Lilly Bounces Into ‘Sell in May’ Territory as Pricing Pressures Loom

The “G-Wagon Loophole”: How Business Owners Write Off a $100,000 SUV the Year They Buy It

‘$13,426 of Stupid’: Dave Ramsey’s Blunt Advice to a Caller Who Maxed Out Credit Cards Flipping Pokemon Cards

The Next 30% Crash Will Happen. These 3 ETFs Mean You Won’t Panic-Sell at the Bottom

Featured Reads

'$13,426 of Stupid': Dave Ramsey's Blunt Advice to a Caller Who Maxed Out Credit Cards Flipping Pokemon Cards

How Corporate Executives Stash $100,000+ Into a 401(k) Using the 415(c) Rule Most People Miss